We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Today's NCE Amey snaps up WYG rail division 01 July 2010 | By Mark Hansford Amey has bought consultant WYG’s rail division to help service its growing workload in the sector.
Date: Thursday 19 Nov 2009 LONDON (ShareCast) - Engineering consultant White Young Green has traded in line with expectations since the end of June, with conditions varying across its markets. “There remains a lack of confidence and liquidity in many areas in which we trade, but there are also some encouraging signs in respect of opportunities and new contract wins,” it said. Shares in Beowulf, which owns mineral exploration projects in Sweden, jumped after it said results from tests of its Lulepotten copper-gold deposit in Northern Sweden appeared favourable compared to another of its deposits in the region. Shares in Angel Biotechnology jumped after the biopharmaceutical contract manufacturer said it would be the contractor on three separate grants that have been awarded to consortia active in regenerative medicine. Oil and gas group GeoPark, which has exploration and production properties in Chile and Argentina, has raised $20.5m through a placing of 3.784m shares at 542 cents each. Technical adhesive tapes firm Scapa Group narrowed its trading loss to £1m in the first half from an underlying deficit of £6.4m in the second half of last year. The firm attributed the improvement to recent restructuring exercises, which significantly reduced the cost base, and 6.6% additional sales volume. A pre-tax profit of £2.7m a year ago turned into a £3.1m loss this time. Events and conferencing group Tarsus extended its rally Thursday on news it has traded as expected since the end of July. The firm, responsible for the Dubai Airshow, said attendances at its events are ahead of previous years, leaving it confident of a satisfactory outcome for 2009 at current exchange rates. Marine electronics group Raymarine has slumped more than a third on falling sales and as it racks up “significant” professional and bank fees in an effort to secure long term refinancing. Sales dropped 26% in the four months to 30 October and by 23% in the last 10 months, or 32% on a like-for-like basis. Raymarine’s existing banking facilities mature on 31 March 2010 and it is currently unable to comply with certain financial covenants within these facilities. It is reliant on continuing covenant waivers, due to expire on 4 December. ImmuPharma’s impressive run has come to an end after a broker disagreed with the drug developer’s claim that its experimental lupus drug met its goals in a Phase II trial. Lupuzor achieved a “clinically significant” improvement in patient response rate and was generally well tolerated, but Panmure Gordon said an early end to the trial meant the threshold for proving statistical significance was raised. But fleet management group Trakm8 has travelled higher after swinging back into profit at the half-way stage due to cost-cutting and a focus on higher margin products and customers. It posted a profit before tax of £100,000 for the s
7 April 2010 WYG plc ( "WYG" or the "Company") Grant of Options On 31 March 2010 WYG announced the grant of certain awards by the trustee of the White Young Green plc 2009 Employee Benefit Trust (the "Trustee") pursuant to the White Young Green plc Performance Share Plan ("PSP"). Since the date of that announcement, there has been a recalculation, such that a reduced number of ordinary shares of 10 pence each ("Shares") have been placed under the awards. The Trustee has granted awards pursuant to the PSP over 4,448,250 Shares which represents 51.54% of the total holding of the Trustee. The announcement on 31 March 2010 reported that awards had been made over 6,212,993 Shares representing 71.98% of the total holding of the Trustee. These figures have been replaced by those set out above. All other details in the announcement made on 31 March 2010 remain the same. For further information, please contact: WYG plc Paul Hamer, Chief Executive Officer Tel: 0113 278 7111 David Wilton, Group Finance Director
Date: Thursday 19 Nov 2009 LONDON (ShareCast) - Engineering consultant White Young Green has traded in line with expectations since the end of June, with conditions varying across its markets. “There remains a lack of confidence and liquidity in many areas in which we trade, but there are also some encouraging signs in respect of opportunities and new contract wins,” it said. Shares in Beowulf, which owns mineral exploration projects in Sweden, jumped after it said results from tests of its Lulepotten copper-gold deposit in Northern Sweden appeared favourable compared to another of its deposits in the region. Shares in Angel Biotechnology jumped after the biopharmaceutical contract manufacturer said it would be the contractor on three separate grants that have been awarded to consortia active in regenerative medicine. Oil and gas group GeoPark, which has exploration and production properties in Chile and Argentina, has raised $20.5m through a placing of 3.784m shares at 542 cents each. Technical adhesive tapes firm Scapa Group narrowed its trading loss to £1m in the first half from an underlying deficit of £6.4m in the second half of last year. The firm attributed the improvement to recent restructuring exercises, which significantly reduced the cost base, and 6.6% additional sales volume. A pre-tax profit of £2.7m a year ago turned into a £3.1m loss this time. Events and conferencing group Tarsus extended its rally Thursday on news it has traded as expected since the end of July. The firm, responsible for the Dubai Airshow, said attendances at its events are ahead of previous years, leaving it confident of a satisfactory outcome for 2009 at current exchange rates. Marine electronics group Raymarine has slumped more than a third on falling sales and as it racks up “significant” professional and bank fees in an effort to secure long term refinancing. Sales dropped 26% in the four months to 30 October and by 23% in the last 10 months, or 32% on a like-for-like basis. Raymarine’s existing banking facilities mature on 31 March 2010 and it is currently unable to comply with certain financial covenants within these facilities. It is reliant on continuing covenant waivers, due to expire on 4 December. ImmuPharma’s impressive run has come to an end after a broker disagreed with the drug developer’s claim that its experimental lupus drug met its goals in a Phase II trial. Lupuzor achieved a “clinically significant” improvement in patient response rate and was generally well tolerated, but Panmure Gordon said an early end to the trial meant the threshold for proving statistical significance was raised. But fleet management group Trakm8 has travelled higher after swinging back into profit at the half-way stage due to cost-cutting and a focus on higher margin products and customers. It posted a profit before tax of £100,000 for the s
GL. ( To us all )
Thank you - yes small punt.
The banks have a stranglehold on WYG.On the other hand, they'll be getting very close supervision and hopefully, very good advice to help them through this tricky spot.A reasonable proposition for a small punt.
Does anyone have a view on these boys ? I understand employee share plan was suspended after the restructuring with the banks. Shares are worth a 10th of what staff paid for them. Do you think staff will hang around ?
Many thanks.
Contact has gone from a four day week to a five day week with higher activity levels but no significant reason he can find for the rise. Big debt.
Have a mate in the company - waiting for a call back later.
Anyone know WTFGO ??? Looks good on sales but spread is disastrous.However, a remarkable rise last few days.Let's hope it continues.GL.
thanks...let's see if we can get a bit more interest. I see it's the top riser so far today.
hear hear i,m with you there welcome to the quietest board on lse!
It's about time this share rose. WYG is now on much more solid ground and winning big contracts.
Well,Well,WELL + 20.14%...Can't see any reason why.Must confess I can't be bothered to seriously research.Anyone know why the rise the last few days.Can't find an RNS/News/etc...Is it a leak of good results?New contracts?What?...I may end up answering myself soon.GL. all.
Got it! LOL.
Sorry : senior moment.Wrong board.Should have been SAR..Anyway...What mean Wondering why? Why what?
Dosage trials have been farmed out to PYC.(They do computer simulations,referred to as "in silico")).This will be paid for out of future deals for licence.A bit difficult to know how to interpret this as both companies share some of their directors..PYC were looking about the right price to buy in at anyway, so I bought some of theirs today as well.This has been seen as effectively a dilution and has effected the SP,probably temporarily.There was a suggestion/ hint that as it was to be paid for by future licencing that a deal seemed to be looking more likely after the trials,however the common directorships muddy the water somewhat. GL.On balance I suggest you should continue to hold.IMHO.DYOR TTFN GL.
just thought i would say hello does anybody know anything about this share? i hold a chunk of these and was wondering why(sic)
Tumbleweed blows slowly across a parched landscape.LOL.You've got to sometimes.Should I write to thank me for my post? No ,perhaps not.Anyone heard anything ? rumours? jokes?
that like me take a casual interest! http://www.wyg.com/2investors/financial-news_detail.php?ric=&ref=44890
White Young Green - Group. http://www.wyg.com/media/
can repeat that again in English? WHY = WYG = White Young Group
I see that why has gone off listing so have google it has come up with this one so church mouse i think you are right with 10 to 1 so wat next than . I hope they put some news out soon on here so ever one noes WATS going on as the WHY is off now so ever one noes that they are still trading